Press release content from Business Wire. The AP news staff was not involved in its creation. Guided Therapeutics Announces Sales and Training Center in Budapest December 21, 2020 GMT PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Dec 21, 2020-- Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced the opening of a new LuViva Reference and Training Center (“Center of Excellence”) in Budapest, Hungary to support sales and training in Europe. The center, established at Budapest Medica Bella Women’s Health Clinic, is co-sponsored by the Company and its European manufacturing and distribution partner, Newmars Technologies, Kft. (Budapest, Hungary). The Center’s primary focus will be to introduce and train physicians from all over Europe in the clinical implementation of LuViva. Newmars Technologies has placed an initial purchase order of single use Cervical Guides for the facility to be used in the training process. LuViva has received the CE Mark with expanded claims for cervical cancer screening through its partnership with Newmars Technologies. The CE Mark enables expanded commercialization of LuViva in 27 EU-associated countries totaling a population of 229 million women.